Alteplase in COVID-19 severe hypoxemic respiratory failure: the TRISTARDS multicenter randomized trial.

Ann Intensive Care · 2024 · PMC11551089 · PMID 39522090

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

marginally significantno p-value reported

Pooling of patient data from Parts 1 and 2 showed a marginally significant reduction in all-cause mortality and improved PaO 2 /FiO 2 ratio in patients receiving alteplase.

also in 26,082 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.